100% accuracy
of data
of data
24/7 scientific
support
support
0% tolerance in
quality of product
quality of product
Stock Locations
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Stock subject to availability.
Documentation
Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.
2095551-20-32'-Alkene Sofosbuvir
● In Stock
| Catalogue No.: | VE009109 |
|---|---|
| CAS No.: | 2095551-20-3 |
| Mol. Formula: | C22H28N3O9P |
| Mol. Weight: | 509.45 g/mol |
Additional information on CAS 2095551-20-3
Parent drug
SofosbuvirIUPAC Name
isopropyl ((S)-(((2R, 3S, 5R)-5-(2, 4-dioxo-3, 4-dihydropyrimidin-1(2H)-yl)-3-hydroxy-4-methylenetetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninateSynonyms
N/ADescription
2'-Alkene Sofosbuvir (CAS No.2095551-20-3) Or isopropyl ((S)-(((2R, 3S, 5R)-5-(2, 4-dioxo-3, 4-dihydropyrimidin-1(2H)-yl)-3-hydroxy-4-methylenetetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate,2'-Alkene Sofosbuvir is an impurity present in Sofosbuvir, Sofosbuvir is a direct-acting antiviral medication, which is used in combination therapy with other antiviral medications to treat chronic hepatitis C virus (HCV) infected patients with HCV genotypes 1-6, and to treat HCV and HIV, co-infected patients.References
‌Bhatia, H. K., Singh, H., Grewal, N., & Natt, N. K. (2014). Sofosbuvir: A novel treatment option for chronic hepatitis C infection. Journal of Pharmacology and Pharmacotherapeutics, 5(4), 278–284. https://doi.org/10.4103/0976-500x.142464 ‌Request a Quote
"*" indicates required fields
Other products related to Sofosbuvir impurities
Impurity structure
Parent Drug Name
CAS No.
Name of Impurity
Catalog No.
Sofosbuvir
CAS No. 1496552-28-3
Cat No. VE009011
Sofosbuvir
CAS No. N/A
Cat No. VE009032
